Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
7 Biotech Stocks That Will Make You Rich in 10 Years
03:44pm, Wednesday, 18'th Jan 2023
If you have the patience to go through wild undulations, then you may be a candidate for biotech stocks that will make you rich in 10 years. Even among the most established biotechnology firms, they'r
6 Analysts Have This to Say About Exelixis
01:00pm, Wednesday, 11'th Jan 2023 Benzinga
Exelixis (NASDAQ:EXEL) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
3
1
0
0
Last 30D
1
0
Strength Seen in Harmony Biosciences Holdings, Inc. (HRMY): Can Its 5.1% Jump Turn into More Strength?
12:56pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
Harmony Biosciences Holdings, Inc. (HRMY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest fu
Exelixis (EXEL) Announces Preliminary Q4 and 2022 Results
06:33pm, Monday, 09'th Jan 2023 Zacks Investment Research
Exelixis (EXEL) reports preliminary revenues for the fourth quarter and 2022. It also provides guidance for 2023 and pipeline updates.
Exelixis (EXEL) Announces Preliminary Q4 and 2022 Results
03:03pm, Monday, 09'th Jan 2023
Exelixis (EXEL) reports preliminary revenues for the fourth quarter and 2022. It also provides guidance for 2023 and pipeline updates.
Four Undervalued Healthcare Stocks for 2023
11:21am, Friday, 06'th Jan 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc.
ALAMEDA, Calif.--( BUSINESS WIRE )--Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company's President and Chief Executive Officer, will provide a corporate overvi
Is Exelixis Stock a Buy Now?
01:15pm, Thursday, 29'th Dec 2022 The Motley Fool
Don't be too quick to dismiss this company as a one-trick pony.
Is Exelixis Stock a Buy Now?
08:15am, Thursday, 29'th Dec 2022
Don't be too quick to dismiss this company as a one-trick pony.
2 Top Biotech Stocks to Buy for the Long Haul
01:30pm, Sunday, 25'th Dec 2022 The Motley Fool
These mid-cap biotechs are solid long-term choices.
2 Top Biotech Stocks to Buy for the Long Haul
08:30am, Sunday, 25'th Dec 2022
These mid-cap biotechs are solid long-term choices.
2 Beaten-Down Growth Stocks to Buy Before the Bull Run
01:45pm, Wednesday, 21'st Dec 2022 The Motley Fool
These could become hot buys once investors pivot back to growth stocks.
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
10:21am, Friday, 16'th Dec 2022 The Motley Fool
Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing biotech stock looks poised to disappoint.
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
05:21am, Friday, 16'th Dec 2022
Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing biotech stock looks poised to disappoint.
Nasdaq Bear Market: 5 Exceptionally Cheap Growth Stocks You'll Regret Not Buying on the Dip
10:06am, Saturday, 10'th Dec 2022 The Motley Fool
These bargain-basement-priced growth stocks are ripe for the picking following a 38% peak decline in the Nasdaq Composite.
